Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0348321 (Haemophilus)
15,372 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The application of a recently described PCR test for the detection of Haemophilus paragallinarum in China is described. The test was used to examine a total of 127 chickens sourced from a challenge trial (38 chickens), a respiratory disease-free experimental chicken farm (50 chickens) and eight farms with suspect infectious coryza (IC) outbreaks (39 chickens). The PCR results were compared with traditional culture. The PCR detected 14/14 infected birds in the challenge trial as compared with 13/14 for culture. The 50 chickens from the disease-free experimental farm were all negative by both PCR and culture. PCR yielded 15/39 birds and 6/8 commercial farms positive as compared with 8/39 birds and 4/8 farms positive by culture. All farms positive by PCR had chickens showing the typical clinical signs of IC, indicating that culture failed to confirm coryza on two farms that had the typical clinical signs of the disease. Although chickens on two commercial farms were thought initially to be suffering from coryza, detailed clinical examination yielded no birds with typical clinical signs. The 12 chickens examined from these two farms were negative by both PCR and culture. The results suggest that the PCR test for H. paragallinarum is a suitable alternative to culture even under the typical field and laboratory conditions that operate in China.
...
PMID:Evaluation of a PCR test for the detection of Haemophilus paragallinarum in China. 1848 1

An unusual bacterium causing respiratory disease in chickens emerged in South Africa in February 1989. The disease resembled infectious coryza but the organism differed from typical Haemophilus paragallinarum especially in that it did not require V-factor for growth. It has been termed an NAD-independent H. paragallinarum. A study of avian haemophili isolated from diseased chickens in Kwazulu-Natal over the past five years revealed the presence of typical H. paragallinarum, NAD-independent H. paragallinarum and H. avium (now transferred to the genus Pasteurella). Before the end of 1989 the NAD-independent H. paragallinarum had become the predominate isolate and thereafter was isolated from commercial chickens in other regions of South Africa. The disease affected all strains of chickens in an overall age range of 14 days to 64 weeks. The organism was responsible for upper respiratory disease of broilers and layers and implicated in lower respiratory disease of broilers. It was commonly isolated from diseased adult birds previously vaccinated against typical H. paragallinarum. Broilers were most commonly infected from 3 weeks of age and layers within the placement to peak production period. Whole cell protein profiles of NAD-independent H. paragallinarum isolates from five different commercial poultry units were identical but differed from that of a typical isolate.
...
PMID:NAD (V-factor)-independent and typical Haemophilus paragallinarum infection in commercial chickens: a five year field study. 1864 2

From early 1989 the emergence of an infectious bacterial disease resembling infectious coryza was seen in several commercial chicken flocks in Natal Province of South Africa. Clinical signs were facial swelling and nasal discharge. An organism was routinely isolated from the infra-orbital sinus or trachea of infected chickens. The organism was found to be a Gram-negative rod, non-motile, V factor (nicotinamide adenine dinucleotide, NAD)-independent, catalase negative, oxidase positive and urease and indole negative. No gas was produced from carbohydrates and acid was produced from glucose, mannitol, inositol and sorbitol. Experimental inoculation of this organism into the infraorbital sinus of SPF chickens and conventional broilers produced an acute upper respiratory disease. The organism could be recovered for up to 7 days post-inoculation. The organism is closely related to Haemophilus paragallinarum, the cause of infectious coryza, but because it is NAD-independent it cannot be classed as an Haemophilus species.
...
PMID:An upper respiratory disease of commercial chickens resembling infectious coryza, but caused by a V factor-independent bacterium. 1867 Sep 57

Garenoxacin mesylate hydrate (GRN) is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity against common respiratory pathogens, including resistant strains. It has favourable pharmacokinetic profiles for maximum plasma concentration (Cmax) and area under the plasma concentration-time curve (AUC), with good penetration into sputum and otorhinolaryngological tissues. In clinical studies, the efficacy of GRN ranged from 92% to 96% in patients with bacterial pneumonia, mycoplasma pneumonia, chlamydial pneumonia and acute bronchitis. Efficacy was 85% in acute infectious exacerbations of chronic respiratory disease and ranged from 81% to 95% in otorhinolaryngological infections. Bacterial eradication was 90.9% for Staphylococcus aureus, 99.2% for Streptococcus pneumoniae, 98.2% for Haemophilus influenzae, 96.6% for Moraxella catarrhalis, 100% for penicillin-resistant S. pneumoniae, 100% for beta-lactamase-negative ampicillin-resistant H. influenzae and beta-lactamase-positive H. influenzae, and 96.2% for beta-lactamase-positive M. catarrhalis. Garenoxacin concentrations in plasma and tissues using GRN 400mg once a day were higher than the MIC90 (minimum inhibitory concentration for 90% of the organisms) of major causative pathogens. The trough concentration (Cmin) in plasma was 1.92 microg/mL, a level that was higher than the mutant prevention concentration, suggesting that GRN is unlikely to induce the selection of resistant strains during treatment. In clinical studies, GRN did not produce class adverse effects of fluoroquinolones such as QTc prolongation, blood glucose abnormality or severe liver damage. No serious adverse events were observed during the trials. The results indicate that GRN is very effective in treating patients with upper and lower respiratory tract infections.
...
PMID:Clinical studies of garenoxacin. 1879 Jun 8

A total of 233 isolates of Pasteurella multocida were obtained from 2,912 cases of clinical respiratory disease in pigs in China, giving an isolation rate of 8.0%. Serogroup A P. multocida isolates were isolated from 92 cases (39.5%), and serogroup D isolates were isolated from 128 cases (54.9%); 12 isolates (5.2%) were untypeable. P. multocida was the fourth most frequent pathogenic bacterium recovered from the respiratory tract, after Streptococcus suis, Haemophilus parasuis, and Escherichia coli. All isolates were characterized for their susceptibilities to 20 antibiotics and the presence of 19 genes for virulence factors (VFs). The frequency of antimicrobial resistance among P. multocida isolates from swine in China was higher than that reported among P. multocida isolates from swine in from other countries, and 93.1% of the isolates showed multiple-drug resistance. There was a progressive increase in the rate of multiresistance to more than seven antibiotics, from 16.2% in 2003 to 62.8% in 2007. The resistance profiles suggested that cephalosporins, florfenicol, and fluoroquinolones were the drugs most likely to be active against P. multocida. Use of PCR showed that colonization factors (ptfA, fimA, and hsf-2), iron acquisition factors, sialidases (nanH), and outer membrane proteins occurred in most porcine strains. The VFs pfhA, tadD, toxA, and pmHAS were each present in <50% of strains. The various VFs exhibited distinctive associations with serogroups: concentrated in serogroup A, concentrated in serogroup D, or occurring jointly in serogroups A and D. These findings provide novel insights into the epidemiological characteristics of porcine P. multocida isolates and suggest that the potential threat of such multiresistant bacteria in food-producing animals should not be neglected.
...
PMID:Isolation, antimicrobial resistance, and virulence genes of Pasteurella multocida strains from swine in China. 1915 60

Histophilus somni (Haemophilus somnus) is an important pathogen of cattle that is responsible for respiratory disease, septicemia, and systemic diseases such as thrombotic meningoencephalitis, myocarditis, and abortion. A variety of virulence factors have been identified in H. somni, including compositional and antigenic variation of the lipooligosaccharide (LOS). Phosphorylcholine (ChoP) has been identified as one of the components of H. somni LOS that undergoes antigenic variation. In this study, five genes (lic1ABCD(Hs) and glpQ) with homology to genes responsible for ChoP expression in Haemophilus influenzae LOS were identified in the H. somni genome. An H. somni open reading frame (ORF) with homology to H. influenzae lic1A (lic1A(Hi)) contained a variable number of tandem repeats (VNTR). However, whereas the tetranucleotide repeat 5'-CAAT-3' is present in lic1A(Hi), the VNTR in H. somni lic1A (lic1A(Hs)) consisted of 5'-AACC-3'. Due to the propensity of VNTR to vary during replication and cause the ORF to shift in and out of frame with the upstream start codon, the VNTR were deleted from lic1A(Hs) to maintain the gene constitutively on. This construct was cloned into Escherichia coli, and functional enzyme assays confirmed that lic1A(Hs) encoded a choline kinase, and that the VNTR were not required for expression of a functional gene product. Variation in the number of VNTR in lic1A(Hs) correlated with antigenic variation of ChoP expression in H. somni strain 124P. However, antigenic variation of ChoP expression in strain 738 predominately occurred through variable extension/truncation of the LOS outer core. These results indicated that the lic1(Hs) genes controlled expression of ChoP on the LOS, but that in H. somni there are two potential mechanisms that account for antigenic variation of ChoP.
...
PMID:Molecular characterization of phosphorylcholine expression on the lipooligosaccharide of Histophilus somni. 1968 67

Histophilus somni is an obligate inhabitant of the respiratory and genital mucosal surfaces of bovines and ovines. An individual strain can be a primary pathogen, an opportunistic pathogen, or a commensal, but can also move between these classifications if introduced into an appropriate site (e.g. the lungs) under conditions that favor bacterial persistence. H. somni is one of the bacterial agents responsible for bovine respiratory disease complex and can also cause a variety of systemic diseases in cattle and sheep. Isolates from disease sites, such as the lungs, heart, and brain, express a wide array of virulence factors (including biofilm formation) designed to evade host defense mechanisms. By contrast, some isolates from the healthy genital tract often lack many of these virulence factors. The genomic sequences of two bovine isolates, one from pneumonic lung and the other from healthy prepuce, have aided in deciphering the differences in phenotype and virulence between the two strains, and reveal their striking genetic similarity to Haemophilus influenzae and other members of the Pasteurellaceae.
...
PMID:A genomic window into the virulence of Histophilus somni. 2003 25

This review of electronic patient records was conducted to identify trends in acute otitis media (AOM) microbiology in the Puget Sound region. Culture results from tympanocentesis procedures performed between July 1, 2005 and June 30, 2009 were compiled into 4 respiratory disease seasons: 2005-2006, 2006-2007, 2007-2008, 2008-2009. Heptavalent pneumococcal conjugate vaccination coverage within the cohort was 85%; average patient age was 13 months (SD = 6.6). The proportion of AOM isolates positive for Streptococcus pneumoniae for the four periods covered was 48%, 41%, 35%, and 54%, respectively (P = 0.185, 3rd to 4th season). For Haemophilus influenzae, the proportions were 42%, 41%, 59%, and 38%, respectively (P = 0.182, 3rd to 4th season). Penicillin resistance among S pneumoniae isolates increased from 13% to 61% across the study period (P = 0.016). S pneumoniae may be regaining prevalence as an otopathogen in PCV7-vaccinated populations, and levels of penicillin resistance are increasing.
...
PMID:Microbiology of acute otitis media, Puget Sound region, 2005-2009. 2018 79

Between January 2003 and September 2008, 652 Bordetella bronchiseptica isolates were cultured from 3506 lung samples collected from pigs with respiratory disease. Over the 6-year period, the average isolation rate was 18.6%, making B. bronchiseptica the fourth most frequently isolated pathogenic bacterium from those lung samples. The isolation rates in different years and provinces ranged from 15.2% to 25.7% and 17.3% to 20.7%, respectively. There were significant influences of sampling month and pig age on bacterial isolation (P<0.05). Streptococcus suis (29.9%), Haemophilus parasuis (26.7%) and Escherichia coli (21.6%) were isolated most frequently in association with B. bronchiseptica. All 12 toxigenic Pasteurella multocida strains co-isolated with B. bronchiseptica from 63 cases of atrophic rhinitis were classified into serogroup D. The results suggest that B. bronchiseptica infection is highly prevalent in pig farms in China, and is often accompanied by co-infection with other bacteria.
...
PMID:The occurrence of Bordetella bronchiseptica in pigs with clinical respiratory disease. 2059 97

While most systemic pediatric Haemophilus influenzae infections are caused by the type b strain (Hib), nontypeable H. influenzae: (NTHi) has been considered a respiratory tract pathogen common in local infection such as acute otitis media, acute pneumonia, secondary chronic respiratory disease and other otorhinolaryngologic infections. Recent findings show, however, that NTHi also causes invasive infections such as meningitis, bacteremia, and lower respiratory tract infections such as pneumonia. A review of NTHi epidemiology from the 1990s onward shows that NTHi causes significant morbidity in pediatric acute otitis media, sinusitis, conjunctivitis and lower respiratory diseases such as pneumonia in Japan. This summary also reviews the worldwide influence of Streptococcus pneumoniae and Hib vaccines on causative pathogens, and several studies about increasing incidence of invasive infections due to NTHi. This review also touches on the emergence of treatment- and drug-resistant H. influenzae, which are now major public health challenges. As a cause of bacterial pediatric infection, NTHi is an important target for prevention.
...
PMID:[Nontypeable Haemophilus influenzae (NTHi) epidemiology]. 2170 41


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>